CARDINAL HEALTH INC shareholders Q3 2023

CARDINAL HEALTH INC's ticker is CAH and the CUSIP is 14149Y108. A total of 935 filers reported holding CARDINAL HEALTH INC in Q3 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

CARDINAL HEALTH INC shareholders Q3 2023
Name	Shares	Value	Weighting ↓
EDMP, INC.	11,954	$1,037,870	1.06%
Delta Accumulation, LLC	54,000	$4,688,280	1.05%
Delta Accumulation, LLC	54,000	$4,688,280	1.05%
Te Ahumairangi Investment Management Ltd	72,977	$6,336	1.03%
Zurich Insurance Group Ltd/FI	1,119,176	$97,166,860	1.03%
Andra AP-fonden	197,100	$17,112,222	1.01%
Birch Capital Management, LLC	17,901	$1,554,165	0.98%
ACADIAN ASSET MANAGEMENT LLC	2,539,244	$220,426	0.92%
CWA Asset Management Group, LLC	139,601	$12,120,137	0.90%
CEERA INVESTMENTS, LLC	18,728	$1,625,965	0.88%
Cairn Investment Group, Inc.	15,326	$1,331	0.88%
LEUTHOLD GROUP, LLC	71,494	$6,207,109	0.87%
WINTON GROUP Ltd	120,508	$10,462,505	0.86%
CLARK FINANCIAL SERVICES GROUP INC /BD	6,901	$599,113	0.82%
Sound Financial Strategies Group, LLC	11,264	$977,940	0.81%
INVESTMENT MANAGEMENT ASSOCIATES INC /ADV	22,257	$1,932,381	0.81%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC	620,333	$53,857,311	0.80%
Iowa State Bank	34,899	$3,029,931	0.79%
FORT, L.P.	3,102	$269,316	0.74%
Redwood Investment Management, LLC	97,858	$8,496	0.74%

About CARDINAL HEALTH INC

Cardinal Health Inc. is a leading healthcare services and products company that provides pharmaceuticals, medical products, and services to hospitals, pharmacies, and healthcare providers. The company operates in two segments: Pharmaceutical and Medical.

The Pharmaceutical segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals, over-the-counter healthcare products, and consumer health products. The Medical segment distributes medical, surgical, and laboratory products to hospitals, surgery centers, and physician offices.

Cardinal Health has a strong presence in the United States and operates in over 60 countries worldwide. The company has a market capitalization of over $15 billion and employs over 50,000 people.

In recent years, Cardinal Health has focused on expanding its product offerings and services to meet the changing needs of the healthcare industry. The company has made several strategic acquisitions, including the acquisition of Medtronic's Patient Care, Deep Vein Thrombosis, and Nutritional Insufficiency businesses.

Cardinal Health has also been recognized for its commitment to sustainability and corporate responsibility. The company has been named to the Dow Jones Sustainability Index for the past 10 years and has received numerous awards for its environmental and social initiatives.

Overall, Cardinal Health is a well-established and respected player in the healthcare industry, with a strong track record of growth and innovation. As the healthcare landscape continues to evolve, Cardinal Health is well-positioned to continue delivering value to its customers and shareholders.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists CARDINAL HEALTH INC's shareholders in Q3 2023. To view CARDINAL HEALTH INC's shareholder history, click here.